Nevro Long Term Debt 2013-2022 | NVRO

Nevro long term debt from 2013 to 2022. Long term debt can be defined as the sum of all long term debt fields.
Nevro Annual Long Term Debt
(Millions of US $)
2022 $187
2021 $151
2020 $142
2019 $160
2018 $152
2017 $145
2016 $138
2015 $20
2014 $20
2013 $
2012 $
Nevro Quarterly Long Term Debt
(Millions of US $)
2022-12-31 $187
2022-09-30 $187
2022-06-30 $186
2022-03-31 $186
2021-12-31 $151
2021-09-30 $149
2021-06-30 $146
2021-03-31 $144
2020-12-31 $142
2020-09-30 $140
2020-06-30 $137
2020-03-31 $162
2019-12-31 $160
2019-09-30 $158
2019-06-30 $156
2019-03-31 $154
2018-12-31 $152
2018-09-30 $151
2018-06-30 $149
2018-03-31 $147
2017-12-31 $145
2017-09-30 $143
2017-06-30 $142
2017-03-31 $140
2016-12-31 $138
2016-09-30 $136
2016-06-30 $135
2016-03-31 $20
2015-12-31 $20
2015-09-30 $20
2015-06-30 $20
2015-03-31 $20
2014-12-31 $20
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.175B $0.406B
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.492B 24.17
Edwards Lifesciences (EW) United States $49.046B 32.63
Alcon (ALC) Switzerland $33.478B 30.63
STERIS (STE) Ireland $18.499B 23.44
Fresenius Medical Care AG KGaA (FMS) Germany $12.188B 12.74
Teleflex (TFX) United States $11.596B 18.91
Penumbra (PEN) United States $10.582B 1630.35
Globus Medical (GMED) United States $5.353B 25.78
Integer Holdings (ITGR) United States $2.578B 19.99
Glaukos (GKOS) United States $2.434B 0.00
Paragon 28 (FNA) United States $1.402B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.348B 17.53
Artivion (AORT) United States $0.496B 244.80